Free Trial 中
Wind ESG Rating

Access to ESG rating for China A-Shares and Hong Kong listed companies.

康龙化成

300759.SZ
Wind Industry: 医疗保健 > 医药生物 > 生命科学工具和服务Ⅲ > 生命科学工具和服务Ⅳ

公司是国际领先的生命科学研发服务企业。自2004年成立以来，公司一直致力于其人才培养和设施建设，为包括小分子、大分子和细胞与基因治疗药物在内的多疗法药物研发打造了一个贯穿药物发现，临床前及临床开发全流程的研发生产服务体系。公司在中国、美国、英国均开展运营，拥有20,000多名员工，向北美、欧洲、日本和中国的合作伙伴提供研发解决方案并与之保持良好的合作关系。

ESG Score Industry Ranking:
9 / 36 (生命科学工具和服务Ⅲ)

ESG Rating Distribution(生命科学工具和服务Ⅲ)

Trend of Rating

2022-04-04: BBB; 2023-04-07: A; 2024-03-29: AA; 2025-04-25: AA; 2026-06-02: AA BBB2022.04 A2023.04 AA2024.03 AA2025.04 AA2026.06

About Wind ESG Rating

Wind has developed a rigorous rating methodology based on the core connotations of ESG, aligning with international standards and frameworks, and incorporating the characteristics of Chinese companies, to assess the company's essential ESG performance, risk and its ability to operate sustainably.

Focusing on the ESG risks and opportunities of each industry, the companies are rated on a AAA-CCC scale relative to the performance of their industry peers. Wind ESG rating is updated annually or in response to major changes.

The Wind ESG Rating Issuer Communication Platform (esg.wind.com.cn) is now available. Rated companies can access their detailed rating information through this platform, and communicate with or provide feedback to the Wind ESG Rating team regarding specific rating components. For any additional questions, please feel free to send an email to GR.ESG@wind.com.cn.

ESG Score

ESG Score：8.05Updated on 2026-10-29
08.0510
Management & Practices Score：5.12Updated on 2026-09-26
05.127
Controversies Score：2.93Updated on 2026-10-29
02.933

ESG Score Comparison

Environmental Social Governance 康龙化成生命科学工具和服务Ⅲ Average
IndicatorCompany ScoreIndustry AverageWeight
Environmental7.673.7915.43%
Social7.435.1558.35%
Governance6.836.3326.22%

Wind ESG Rating Framework

Building on the foundation of domestic and international ESG policies and standards, our proprietary ESG rating framework considers the development of Chinese capital market and integrates the characteristics of the Chinese companies in various industries. The Wind ESG Rating framework is composed of management & practice and controversies assessment, including:

  • 500+ management & practices indicators, covering E, S and G pillars, reflecting long-term ESG fundamental impacts
  • 1,200+ risk labels, covering news, regulatory penalties and lawsuits, reflecting impact of short-term risks

Management & practice score is the weighted summation of E, S and G pillar scores. The weights reflect both the relative impact of each issue within each industry and the negative or positive contribution of each industry to the environment and society relative to other industries.

Controversies score and ESG score are updated daily, E, S and G pillar scores and management & practice score are updated with underlying data, corresponding data are released on various channels, including Wind Financial Terminal.

Explore More

Wind ESG Rating Methodology.pdf1,198KB Wind ESG Ratings FAQs.pdf755KB
More Details

Peer Comparison(36 companies in the industry) ?

RankingCodeSecurity NameESG RatingESG ScoreControversies ScoreManagement & Practices ScoreEnvironmentalSocialGovernance
1688114.SH华大智造AA8.822.985.856.928.778.25
2300725.SZ药石科技AA8.523.005.528.877.338.55
3002821.SZ凯莱英A8.442.985.476.417.968.30
4301230.SZ泓博医药AA8.332.975.366.798.137.13
5688131.SH皓元医药AA8.312.995.316.307.847.79
6688238.SH和元生物AA8.212.785.434.788.617.58
7688202.SH美迪西AA8.192.975.225.247.937.68
8688222.SH成都先导AA8.112.995.126.027.597.46
9300759.SZ康龙化成AA8.052.935.127.677.436.83
9603259.SH药明康德AA8.052.995.077.746.568.46